| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
VLG Stock Overview
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally.
Rewards
Risk Analysis
Venture Life Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.34 |
| 52 Week High | UK£1.02 |
| 52 Week Low | UK£0.27 |
| Beta | -0.087 |
| 1 Month Change | 1.49% |
| 3 Month Change | -5.56% |
| 1 Year Change | -62.64% |
| 3 Year Change | -32.00% |
| 5 Year Change | -41.38% |
| Change since IPO | -68.37% |
Recent News & Updates
Is Venture Life Group (LON:VLG) A Risky Investment?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Shareholder Returns
| VLG | GB Personal Products | GB Market | |
|---|---|---|---|
| 7D | 1.5% | 1.0% | 0.8% |
| 1Y | -62.6% | -3.7% | -6.4% |
Return vs Industry: VLG underperformed the UK Personal Products industry which returned -3.7% over the past year.
Return vs Market: VLG underperformed the UK Market which returned -6.4% over the past year.
Price Volatility
| VLG volatility | |
|---|---|
| VLG Average Weekly Movement | 8.3% |
| Personal Products Industry Average Movement | 7.8% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in GB Market | 10.8% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: VLG is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: VLG's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 145 | Jerry Randall | https://www.venture-life.com |
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness.
Venture Life Group plc Fundamentals Summary
| VLG fundamental statistics | |
|---|---|
| Market Cap | UK£43.01m |
| Earnings (TTM) | UK£2.40m |
| Revenue (TTM) | UK£32.76m |
17.9x
P/E Ratio1.3x
P/S RatioIs VLG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VLG income statement (TTM) | |
|---|---|
| Revenue | UK£32.76m |
| Cost of Revenue | UK£19.80m |
| Gross Profit | UK£12.96m |
| Other Expenses | UK£10.56m |
| Earnings | UK£2.40m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.019 |
| Gross Margin | 39.55% |
| Net Profit Margin | 7.33% |
| Debt/Equity Ratio | 11.6% |
How did VLG perform over the long term?
See historical performance and comparison